Dubai (19 April 2012): Patients with rheumatic heart disease (RHD) are being admitted to hospital too late to prevent the need for heart surgery, according to a new study carried out by doctors in Yemen and presented today at the World Congress of Cardiology.
RHD is a devastating consequence of repeated episodes of rheumatic fever. The disease progresses over time and if it is not caught in the early stages, patients develop heart valve damage and will ultimately need surgery to replace the damaged valve(s).
A recent study in Yemen showed that 43 per cent (n=89/206) of patients admitted to hospital with RHD had rheumatic mitral stenosis – a narrowing of the opening of the heart's mitral value – and more than half were considered to have severe stenosis. Of those 87 patients followed, 53 per cent were recommended for percutaneous balloon mitral valvuloplasty (BMVP) – where the abnormally thickened mitral valve is dilated; a further 29 per cent were recommended for valve replacement surgery; while only 18 per cent were entered into a follow-up programme without interventional therapy of any kind.
"These results clearly demonstrate that RHD patients are seeking treatment from their doctors in the very late stages of their disease," said Dr. A. Sharafaddeen, Algomori Hospital, Taiz, Yemen. "But the management of these patients is costly. This money could be rather used much more efficiently in preventing and screening for the disease in its early stages."
Indeed, coordinated screening and control programmes to prevent progression to severe RHD can be carried out relatively cheaply.
"RHD can be prevented easily using penicillin – a cheap and readily available treatment," said Dr. Fahad Baslaib, President, Emirates Cardiac Society. "The funding required is minimal and control could be achieved by re-prioritizing existing budgets. We therefore have to consider implementing screening programmes in this region as a matter of urgency."
RHD is a substantial global health problem that can result in irreversible heart damage and death. It occurs predominately in developing countries and is also common in poorer populations in middle-income countries (e.g. Brazil, India) and some indigenous populations in wealthy countries (Australia, New Zealand). RHD will continue to be a global problem unless current prevention initiatives are expanded and sustained.
Previous estimates state that more than 15 million people have RHD and that 350,000 people die each year while many more are left disabled.About the World Congress of Cardiology
Charanjit Jagait | EurekAlert!
Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy